KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Income from Non-Controlling Interests (2016 - 2018)

Vertex Pharmaceuticals (VRTX) has 8 years of Income from Non-Controlling Interests data on record, last reported at -$25.4 million in Q4 2018.

  • For Q4 2018, Income from Non-Controlling Interests fell 1794.27% year-over-year to -$25.4 million; the TTM value through Dec 2019 reached -$26.8 million, down 173.98%, while the annual FY2018 figure was -$9.8 million, 752.43% down from the prior year.
  • Income from Non-Controlling Interests reached -$25.4 million in Q4 2018 per VRTX's latest filing, down from -$290000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $28.4 million in Q2 2016 and bottomed at -$188.3 million in Q3 2017.
  • Average Income from Non-Controlling Interests over 5 years is -$11.2 million, with a median of -$290000.0 recorded in 2018.
  • Peak YoY movement for Income from Non-Controlling Interests: surged 5741.84% in 2016, then crashed 26956.75% in 2017.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$4.2 million in 2014, then surged by 77.61% to -$938000.0 in 2015, then plummeted by 452.88% to -$5.2 million in 2016, then surged by 128.94% to $1.5 million in 2017, then crashed by 1794.27% to -$25.4 million in 2018.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were -$25.4 million in Q4 2018, -$290000.0 in Q3 2018, and -$1.1 million in Q2 2018.